BioLight Life Sciences Ltd. (BOLT.TA)

ILA 642.0

(0.0%)

EBITDA Summary of BioLight Life Sciences Ltd.

BioLight Life Sciences Ltd.'s latest annual EBITDA in 2023 was -10.6 Million ILS , down -9.11% from previous year.
BioLight Life Sciences Ltd.'s latest quarterly EBITDA in 2024 Q2 was -4.86 Million ILS , down 0.0% from previous quarter.
BioLight Life Sciences Ltd. reported an annual EBITDA of -8.03 Million ILS in 2022, up 13.23% from previous year.
BioLight Life Sciences Ltd. reported an annual EBITDA of -1.31 Million ILS in 2021, up 16.81% from previous year.
BioLight Life Sciences Ltd. reported a quarterly EBITDA of -5.56 Million ILS for 2023 Q2, down 0.0% from previous quarter.
BioLight Life Sciences Ltd. reported a quarterly EBITDA of -5.04 Million ILS for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of BioLight Life Sciences Ltd. (2023 - 2012)

Historical Annual EBITDA of BioLight Life Sciences Ltd. (2023 - 2012)

Year	EBITDA	EBITDA Growth
2023	-10.6 Million ILS	-9.11%
2022	-8.03 Million ILS	13.23%
2021	-1.31 Million ILS	16.81%
2020	-10.83 Million ILS	8.69%
2019	-13.81 Million ILS	-127.24%
2018	-18.08 Million ILS	304.08%
2017	-26.52 Million ILS	2.52%
2016	-27.21 Million ILS	-7.77%
2015	-25.25 Million ILS	-6.77%
2014	-29.72 Million ILS	13.61%
2013	-27.37 Million ILS	-33.53%
2012	-20.5 Million ILS	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-4.86 Million ILS	0.0%
2023 Q2	-5.56 Million ILS	0.0%
2023 Q4	-5.04 Million ILS	0.0%
2023 FY	- ILS	-9.11%
2022 Q4	-5.48 Million ILS	0.0%
2022 FY	- ILS	13.23%
2022 Q2	-4.75 Million ILS	0.0%
2021 Q4	-5.28 Million ILS	0.0%
2021 Q2	-5.24 Million ILS	0.0%
2021 FY	- ILS	16.81%
2020 FY	- ILS	8.69%
2020 Q4	-5.21 Million ILS	-198.57%
2020 Q3	-1.74 Million ILS	44.39%
2020 Q2	-3.13 Million ILS	20.11%
2020 Q1	-3.92 Million ILS	13.54%
2019 Q4	-4.54 Million ILS	-7.65%
2019 Q1	-4.01 Million ILS	29.5%
2019 Q2	-2.51 Million ILS	37.46%
2019 Q3	-4.22 Million ILS	-68.06%
2019 FY	- ILS	-127.24%
2018 Q3	70.47 Million ILS	1343.16%
2018 Q1	-5.15 Million ILS	7.93%
2018 Q2	-5.66 Million ILS	-9.91%
2018 FY	- ILS	304.08%
2018 Q4	-5.69 Million ILS	-108.08%
2017 Q2	-7.15 Million ILS	-11.92%
2017 Q4	-5.6 Million ILS	27.49%
2017 Q3	-7.72 Million ILS	-7.97%
2017 FY	- ILS	2.52%
2017 Q1	-6.39 Million ILS	8.74%
2016 Q4	-7 Million ILS	-37.91%
2016 Q3	-5.08 Million ILS	10.26%
2016 FY	- ILS	-7.77%
2016 Q2	-5.66 Million ILS	41.08%
2016 Q1	-9.6 Million ILS	-25.07%
2015 Q1	-6.02 Million ILS	-20.59%
2015 Q4	-7.68 Million ILS	-63.03%
2015 Q3	-4.71 Million ILS	23.01%
2015 Q2	-6.12 Million ILS	-1.64%
2015 FY	- ILS	-6.77%
2014 Q3	-7.22 Million ILS	-69.99%
2014 Q2	-4.24 Million ILS	0.0%
2014 FY	- ILS	13.61%
2014 Q4	-4.99 Million ILS	30.87%
2013 FY	- ILS	-33.53%
2013 Q4	-13.95 Million ILS	0.0%
2013 Q2	-13.42 Million ILS	0.0%
2012 FY	- ILS	0.0%

Peer EBITDA Comparison of BioLight Life Sciences Ltd.

Name	EBITDA	EBITDA Difference
Matricelf Ltd	-11.51 Million ILA	7.896%